Development of a monoclonal antibody for the detection of anti-canine CD20 chimeric antigen receptor expression on canine CD20 chimeric antigen receptor-transduced T cells

被引：4

作者：

Sakai, Osamu ^{[1
]}

Ogino, Shoji ^{[2
]}

Tsukui, Toshihiro ^{[2
]}

Igase, Masaya ^{[1
]}

Mizuno, Takuya ^{[1
]}

机构：

[1] Yamaguchi Univ, Joint Grad Sch Vet Med, Lab Mol Diagnost & Therapeut, 1677-1 Yoshida, Yamaguchi 7538515, Japan

[2] Nippon Zenyaku Kogyo Co Ltd, Koriyama, Fukushima 9630196, Japan

来源：

JOURNAL OF VETERINARY MEDICAL SCIENCE | 2021年 / 83卷 / 10期

关键词：

adoptive immunotherapy; canine; CD20; chimeric antigen receptorT cell; monoclonal antibody; RITUXIMAB; LYMPHOMA; THERAPY; MODEL; DOGS;

D O I：

10.1292/jvms.21-0326

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

Chimeric antigen receptor (CAR) CAR-T cell therapy targeting CD20 can be a novel adoptive cell therapy for canine patients with B-cell malignancy. After injection of the CAR-T cells in vivo, monitoring circulating CAR-T cells is essential to prove in vivo persistence of CAR-T cells. In this study, we developed a novel monoclonal antibody against canine CD20 CAR, whose single-chain variable fragment was derived from the our previously reported anti-canine CD20 therapeutic antibody. Furthermore, we proved that this monoclonal antibody can detect therapeutic anti-canine CD20 chimeric antibody in the serum from healthy beagle dogs injected with the therapeutic antibody for safety study. This monoclonal antibody is a useful tool for monitoring both canine CD20-CAR-T cells and anti-canine CD20 therapeutic antibody for canine lymphoma.

引用

页码：1495 / 1499

页数：5

共 50 条

[21] Chimeric antigen receptor-modified T cells: CD19 and the road beyond [J].

Salter, Alexander I. ;

Pont, Margot J. ;

Riddell, Stanley R. .

BLOOD, 2018, 131 (24) :2621-2629

[22] The clinical and biological role of CD20 membrane antigen modulation under immunotherapy with anti-CD20 monoclonal antibody rituximab in lymphoprolipherative neoplastic disorders [J].

Musto, Pellegrino ;

D'Auria, Fiorella .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (05) :551-557

[23] The efficacy of anti-CD19 chimeric antigen receptor T cells for B-cell malignancies [J].

Cao, Jun-Xia ;

Gao, Wei-Jian ;

You, Jia ;

Wu, Li-Hua ;

Liu, Jin-Long ;

Wang, Zheng-Xu .

CYTOTHERAPY, 2019, 21 (07) :769-781

[24] Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells [J].

Morita, Daisuke ;

Nishio, Nobuhiro ;

Saito, Shoji ;

Tanaka, Miyuki ;

Kawashima, Nozomu ;

Okuno, Yusuke ;

Suzuki, Satoshi ;

Matsuda, Kazuyuki ;

Maeda, Yasuhiro ;

Wilson, Matthew H. ;

Dotti, Gianpietro ;

Rooney, Cliona M. ;

Takahashi, Yoshiyuki ;

Nakazawa, Yozo .

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2018, 8 :131-140

[25] Loss of CD20 and Bound CD20 Antibody from Opsonized B Cells Occurs More Rapidly Because of Trogocytosis Mediated by Fc Receptor-Expressing Effector Cells Than Direct Internalization by the B Cells [J].

Beum, Paul V. ;

Peek, Elizabeth M. ;

Lindorfer, Margaret A. ;

Beurskens, Frank J. ;

Engelberts, Patrick J. ;

Parren, Paul W. H. I. ;

van de Winkel, Jan G. J. ;

Taylor, Ronald P. .

JOURNAL OF IMMUNOLOGY, 2011, 187 (06) :3438-3447

[26] Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture Conditions [J].

Lee, Sang Yun ;

Olsen, Philip ;

Lee, Dong Hoon ;

Kenoyer, Aimee L. ;

Budde, Lihua E. ;

O'Steen, Shyril ;

Green, Damian J. ;

Heimfeld, Shelly ;

Jensen, Michael C. ;

Riddell, Stanley R. ;

Press, Oliver W. ;

Till, Brian G. .

JOURNAL OF IMMUNOTHERAPY, 2018, 41 (01) :19-31

[27] Donor-derived CD19 chimeric antigen receptor T cells [J].

Singh, Nathan ;

Barrett, David M. .

CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) :503-508

[28] Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies [J].

Chen, Kevin H. ;

Wada, Masayuki ;

Firor, Amelia E. ;

Pinz, Kevin G. ;

Jares, Alexander ;

Liu, Hua ;

Salman, Huda ;

Golightly, Marc ;

Lan, Fengshuo ;

Jiang, Xun ;

Ma, Yupo .

ONCOTARGET, 2016, 7 (35) :56219-56232

[29] Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti- CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group [J].

Wada, Naoki ;

Kohara, Masaharu ;

Ogawa, Hiroyasu ;

Sugiyama, Haruo ;

Fukuhara, Shirou ;

Tatsumi, Yoichi ;

Kanamaru, Akihisa ;

Hino, Masayuki ;

Kanakura, Yuzuru ;

Morii, Eiichi ;

Aozasa, Katsuyuki .

CASE REPORTS IN ONCOLOGY, 2009, 2 (03) :194-201

[30] Blockade of CD7 expression in T cells for effective chimeric antigen receptor targeting of T-cell malignancies [J].

Png, Yi Tian ;

Vinanica, Natasha ;

Kamiya, Takahiro ;

Shimasaki, Noriko ;

Coustan-Smith, Elaine ;

Campana, Dario .

BLOOD ADVANCES, 2017, 1 (25) :2348-2360

← 1 2 3 4 5 →